Get started

Aytu BioPharma, Inc

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

AYTU chart

Key stats

Market capitalization
6.351MUSD
Dividends yield (FY)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−60.38USD

About Aytu BioPharma, Inc

Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Joshua R. Disbrow
Website
aytubio.com
Headquarters
Englewood
Employees
164
Founded
2002
ISIN
US0547548588

Aytu Biopharma, Inc. is a specialty pharmaceutical company, which focuses on identifying, acquiring, and commercializing novel products. Its products include Adzenys ER, Adzenys XR-ODT, Cotempla XR-ODT, Karbinal ER, Poly-Vi-Flor, Tri-Vi-Flor, Generic Tussionex, Tuzistra XR and ZolpiMist. The company was founded on August 9, 2002 and is headquartered in Englewood, CO.

Ideas

Aytu BioPharma (USA: $AYTU) Trading For Less Than $1 Dollar! 🧬Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in pat
Long
1
AYTU All Time Low | Fast Track Designation form FDA todayAYTU Aytu BioPharma announced today that the FDA has granted Fast Track designation to AR101, a protein kinase inhibitor, for the treatment of patients with Vascular Ehlers-Danlos Syndrome. After the bullish news, AYTU stock hit the all time low level. 52 Week Range 0.76 - 7.20 LADENBURG THALM has
Long
1
AYTUWhat happened here?! The fib potential is perhaps the biggest I have ever seen. The 0.236 (usually easy to hit) is way above there with a modest 11652x Fib top is an insane 393316x from its current price Imagine if a few million crayon eaters find this one day.
HEALIGHT PATENT approval 11/23The most bearish of tickers but things change... sometimes very quickly The HL device will have a huge impact in reducing the length of hospital stays due to VAP and other respiratory illnesses as well as a number of benefits for its outpatient potential. Hint: when hospitals and insurance companie
AYTU BioPharma (NASDAQ: $AYTU) Oversold & Ready To Reverse 🧬Aytu BioPharma: Helping children get off to a healthier start and a better life. Aytu is committed to improving the health of all children. We’re developing a portfolio of products to help children be their best and now expanding into ADHD. Our Adult and consumer health products remain an important
Long
1
AYTU BioPharma (NASDAQ: $AYTU) Could See Massive Upside 🧪🧪🧪Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Nates
Long
2
$AYTU ShortDescending wedge in the making. Shorts owned this ticker and showed an intraday head and shoulders yesterday (I took profits) Bearish flow for now. Waiting for a retest of support and maybe a gap fill for another long position. Gap at 4.80s Good luck.
AYTU Finally Waking Up?AYTU has been under pressure forever with the 50 DMA being the strongest level of resistance over the last few months. However, if you take the chart waaayyyyy out, you'll see that it's bouncing off of a historic level of support, which was confirmed after this latest move. Yet again the 50DMA deni

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.

Financials

Past performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.44Fabulous
Learn more
OANDA
OANDA
Forex
4.52Great
Learn more
FOREX.com
FOREX.com
Forex
4.37Fabulous
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.35Fabulous
Learn more

See all brokers 

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more